<sup>18</sup>F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyDaniel R. Schonhaut, Gil D. Rabinovici, Corey T. McMillan et al.|Annals of Neurology|2017Cited by 175
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseasesMichael Benatar, Joanne Wuu, Caroline McHutchison et al.|Brain|2021Cited by 116
Cell environment shapes TDP-43 function with implications in neuronal and muscle diseaseUrša Šušnjar, Towfique Raj, Vivianna M. Van Deerlin et al.|Communications Biology|2022Cited by 52
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysisMichael Benatar, Eric A. Macklin, Andrea Malaspina et al.|EBioMedicine|2024Cited by 43
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approachesCorey T. McMillan, Michael Benatar, Joanne Wuu et al.|Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration|2022Cited by 41